ATS 2018 International Conference - Mobile

A Phase I, Randomized, Observer-Blinded, Placebo-Controlled, Single and Multiple Ascending-Dose Study to Investigate the Safety, Pharmacokinetics, and Immunogenicity of BITS7201A in Healthy Volunteers [Board No. P890]

Location: Board no. P890

Session Type: Thematic Poster Session

Sunday

May

20

11:15 AM

1:00 PM

Speaker(s)/Author(s)

Flavia Brunstein

MD, PhD
Genentech, Inc.

Kathila Rajapaksa

PhD
Genentech, Inc.

Kun Peng

PhD
Genentech, Inc.

Ian Templeton

PhD
Genentech, Inc.

Alice Fong

PharmD
Genentech, Inc.

David F. Choy

BS
Genentech, Inc;Genentech, Inc.

Tracy Staton

PhD
Genentech, Inc;Genentech, Inc.

Hubert Chen

MD, MPH
Genentech, Inc.

Christopher Cabanski

PhD
Genentech, Inc.

View Abstract

A Phase I, Randomized, Observer-Blinded, Placebo-Controlled, Single and Multiple Ascending-Dose Study to Investigate the Safety, Pharmacokinetics, and Immunogenicity of BITS7201A in Healthy Volunteers

Parent Sessions

A34 - ASTHMA CLINICAL STUDIES I
05-20-2018 9:15 AM - 4:15 PM